You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0705 EULAR sjÖgren’s syndrome disease activity index (ESSDAI) is sensitive to show treatment efficacy of rituximab in patients with primary sjÖgren’s syndrome

Alerts

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
SLE, Sjögren’s and APS – clinical aspects (other than treatment)
AB0705 EULAR sjÖgren’s syndrome disease activity index (ESSDAI) is sensitive to show treatment efficacy of rituximab in patients with primary sjÖgren’s syndrome
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address